US Patent Issued to INTRABIO on June 17 for "Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function" (British, German Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,733, issued on June 17, was assigned to INTRABIO LTD. (Begbrook, Great Britain).

"Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function" was invented by Mallory Factor (London) and Michael Strupp (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to acetyl-leucine or a pharmaceutically acceptable salt thereof for use in improving cognitive function, mobility, or cognitive function and mobility in a subject, for example, in an elderly subject."

The patent was filed on July 10, 2023, under Application No. 18/349,221.

*For further information, including images,...